Back to AVIVA PLC

ABT
Showing 8 of 30 quarters

Position history for AVIVA PLC's holdings in ABBOTT LABORATORIES

AVIVA PLC holds 2.3M shares of ABT (ABBOTT LABORATORIES), worth $235.9M as of 2026-Q1. The position was increased (+0.7% shares). ABT represents 0.4% of AVIVA PLC's portfolio.

Current Value

$235.9M

Current Shares

2.3M

Total Value Change

+$114.1M

Total Shares Change

+1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
2.3M
+0.7%
$235.9M0.4%$113.61
37
2025-Q4
Increased
2.3M
+1.6%
$285.9M0.5%$125.15
37
2025-Q3
Increased
2.2M
+25.8%
$300.8M0.5%$131.85
54
2025-Q2
Increased
1.8M
+25.3%
$242.8M0.5%$132.52
53
2025-Q1
Increased
1.4M
+12.8%
$188.9M0.5%$128.41
41
2024-Q4
Increased
1.3M
+4.1%
$142.8M0.4%$110.14
38
2024-Q3
Increased
1.2M
+3.5%
$138.3M0.4%$109.27
37
2024-Q2
Increased
1.2M
+15.3%
$121.7M0.3%$100.45
41

Other major holders of ABT: VANGUARD GROUP INC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used